Medicalsystem Biotechnology Co.,Ltd.’s Net Profit Dropped 4.2% in First Quarter of 2022

Medicalsystem Biotechnology Co.,Ltd. (美康生物科技股份有限公司) (300439.SZ) reported a net profit of 68 million yuan in the first quarter of 2022, down 4.2% year-on-year.

Meanwhile, the company posted 577.4 million yuan in revenue, up 8.7% year-on-year.

At the end of the reporting period, it had 3.5 billion yuan in total assets and 1.1 billion yuan in total liabilities, with a liability-to-asset ratio of 31.5%.